Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 373 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Breast Cancer Patient Raising Money for 55 Women to Get Mammograms... December 4, 2020 Reunión anual de la American Society of Clinical Oncology de 2023:... June 5, 2023 Breast Cancer Survivor Given 12 Months to Live After Left Side... April 2, 2021 FDA Approves Nivolumab in Combination with Chemotherapy and Nivolumab in Combination... June 8, 2022 Load more HOT NEWS Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II... Molecular Determinants of Sotorasib Efficacy in Patients with Advanced KRASG12C-mutated NSCLC Urine test for bladder cancer being developed Molecular Profiling Identifies Targetable Alterations in Majority of Patients with Advanced...
